Results 1 to 10 of about 54,415 (288)

Macrolides

South African Family Practice, 1988
No abstract available.
A.L. Heyns
openaire   +3 more sources

Macrolides Decrease the Proinflammatory Activity of Macrolide-Resistant Streptococcus pneumoniae

Microbiology Spectrum, 2023
Over the past 2 decades, the prevalence of macrolide-resistant Streptococcus pneumoniae (MRSP) has increased considerably, due to widespread macrolide use.
Hisanori Domon, Satoru Hirayama, Toshihito Isono, Karin Sasagawa, Fumio Takizawa, Tomoki Maekawa, Katsunori Yanagihara, Yutaka Terao   +7 more
doaj   +1 more source

Prevalence and Antibiotic Susceptibility Patterns of Mycoplasma Hominis and Ureaplasma Urealyticum in Females with Genital Infections from Central Kerala, India [PDF]

Journal of Clinical and Diagnostic Research, 2021
Introduction: Genital mycoplasmas namely Mycoplasma Hominis and Ureaplasma Urealyticum are sexually transmitted disease pathogens which are associated with genital infections, infertility, obstetric and neonatal complications.
SNEHA RAJAN, Suryakala R Nair
doaj   +1 more source

Macrolides: From Toxins to Therapeutics

Toxins, 2021
Macrolides are a diverse class of hydrophobic compounds characterized by a macrocyclic lactone ring and distinguished by variable side chains/groups. Some of the most well characterized macrolides are toxins produced by marine bacteria, sea sponges, and ...
Kiersten D. Lenz, Katja E. Klosterman, Harshini Mukundan, Jessica Z. Kubicek-Sutherland   +3 more
doaj   +1 more source

Macrolides and pneumonia [PDF]

Thorax, 2013
Community acquired pneumonia (CAP) is increasing in incidence, and is presently responsible for about 1% of emergency medical admissions with an associated mortality of between 5% and 24%. Improving the outcome of CAP is, therefore, a major health priority, but what is the best method to do this?
Jeremy Stuart, Brown, Adam T, Hill
openaire   +2 more sources

Immunomodulation of endothelial cells induced by macrolide therapy in a model of septic stimulation

Immunity, Inflammation and Disease, 2021
Objectives Sepsis is defined as the host's inflammatory response to a life‐threatening infection. The endothelium is implicated in immunoregulation during sepsis. Macrolides have been proposed to display immunomodulatory properties.
Stéphanie Pons, Eden Arrii, Marine Arnaud, Maud Loiselle, Juliette Ferry, Manel Nouacer, Julien Lion, Shannon Cohen, Nuala Mooney, Lara Zafrani   +9 more
doaj   +1 more source

Long-Term Macrolides in Chronic Respiratory Diseases: Dusk or a New Dawn? A Narrative Review. [PDF]

Antibiotics (Basel)
Macrolides—especially azithromycin—have been increasingly investigated in chronic respiratory diseases for their combined antimicrobial, anti-inflammatory, and immunomodulatory properties.
Previtero D, Castelli G, Padrin Y, Santello V, Mengato D, Biondini D, Turato G, Tiné M, Spagnolo P, Semenzato U.   +9 more
europepmc   +2 more sources

Genome-Wide Association Study Reveals Genetic Markers for Antimicrobial Resistance in Mycoplasma bovis

Microbiology Spectrum, 2021
Mycoplasma bovis causes many health and welfare problems in cattle. Due to the absence of clear insights regarding transmission dynamics and the lack of a registered vaccine in Europe, control of an outbreak depends mainly on antimicrobial therapy ...
Jade Bokma, Nick Vereecke, Hans Nauwynck, Freddy Haesebrouck, Sebastiaan Theuns, Bart Pardon, Filip Boyen   +6 more
doaj   +1 more source

Expert recommendations on the role of macrolides in chronic respiratory diseases

Lung India, 2021
Background: India contributes to 32% of the total global disability-adjusted life years, due to chronic respiratory diseases. This has led to a high rate of health loss from these diseases.
Raja Dhar, Deepak Talwar, Virendra Singh, Harjit Dumra, Sujeet Rajan, S K Jindal   +5 more
doaj   +1 more source

The Utility of Macrolide Therapy for Neutrophilic CRSsNP Based on Structured Histopathology. [PDF]

Laryngoscope
The Laryngoscope, Volume 136, Issue 7, Page 2839-2841, July 2026.
Yu AJ, Venkatesh S, Wilensky J, Workman AD, Chang J, Espinosa M, Douglas JE, Palmer JN, Adappa ND, Kohanski MA.   +9 more
europepmc   +2 more sources